戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 TSPyV) occur during primary infection of the immunosuppressed host.
2 uce Pcp when the organism is acquired by the immunosuppressed host.
3 mans cells as they produced meningitis in an immunosuppressed host.
4 anting further analysis of virus subtypes in immunosuppressed hosts.
5 in normal hosts cause significant disease in immunosuppressed hosts.
6 viral therapy exists for adenovirus (ADV) in immunosuppressed hosts.
7  of niches, including soils and the lungs of immunosuppressed hosts.
8 han non-barrier transplanted organs, even in immunosuppressed hosts.
9  solid organ transplant recipients and other immunosuppressed hosts.
10 otracted SARS-CoV-2 infection, especially in immunosuppressed hosts.
11 ortunistic infection, especially in severely immunosuppressed hosts.
12 n of the JC virus, which generally occurs in immunosuppressed hosts.
13 K variants arising in immunocompetent versus immunosuppressed hosts; and 2) by investigating the effe
14 reactivation of the latent adenovirus in the immunosuppressed host as the source of infection.
15 on of hepatocytes, so it is paradoxical that immunosuppressed hosts have higher rates of fibrosis pro
16                                       In the immunosuppressed host, however, a wide spectrum of infec
17                          Most cases occur in immunosuppressed hosts, including patients with HIV/AIDS
18      Cryptosporidium parvum infection in the immunosuppressed host is frequently complicated by bilia
19 esistance in intensive care units, expanding immunosuppressed host populations, and public health cri
20                          By contrast, in the immunosuppressed host TIMP-1 mRNA was expressed by CNS r
21 for Epstein-Barr virus (EBV) pathogenesis in immunosuppressed hosts, we studied experimental infectio
22                                     Here, in immunosuppressed hosts, we uncover rare naturally arisin
23 lted from incomplete viral suppression in an immunosuppressed host with a high viral load.
24                                           In immunosuppressed hosts with a high organism burden, orga
25 en recognized to be pathogenic in profoundly immunosuppressed hosts with increasing frequency, this i